N

NeuroGut AI

Bishopp Lab Pty Ltd

neurogutai.com →

Pitch Deck

Measuring gut-brain physiology, signal by signal

Investor and grant-reviewer overview. Problem, product, validated metrics, partnerships, commercial model, and what we are looking for next.

Watch the platform (2 min)

A short narrated walkthrough of NeuroGut: the everyday gap in gut-brain wellness, the recording experience, the wellness readiness score, and the guided biofeedback loop. The full pitch deck is below.

Product

Mobile app live on the App Store and Google Play. A companion hardware device is in early development toward a future regulated clinical pathway.

Validated metrics

Heart rate accuracy within ±1 BPM, validated across 20 testers and 1,000+ sessions. Purpose-built on-device signal model with sub-200ms inference; early internal accuracy benchmarks are tracking well on held-out data.

Founders

Michael Bishopp (co-founder & CEO, 29 years clinical experience, IBS patient himself), Merryck Bishopp (co-founder & CTO, engineering and ML) and Maitland Bishopp (co-founder, Legal & Regulatory, Herbert Smith Freehills).

Partners

AiSteth (hardware integration partner). AI Highway Research (AI R&D collaboration). Griffith University (prototyping facility access). Clinical-validation pathway in early-stage scoping.